Medical/Pharmaceuticals
Kazia Enrols First Patient to EVT801 Phase I Clinical Trial
SYDNEY, Nov. 4, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it has commenced enrolment to a phase I clinical trial of EVT801, an investigational cancer therapy that Kazia licensed from Evotec S...
2021-11-04 08:38
4057
Sensational artemisinin-piperaquine for treatment of COVID-19 in prospect
GUANGZHOU, China, Nov. 3, 2021 /PRNewswire/ -- Artequick artemisinin and piperaquine tablets have once again become buzzwords across the globe, as most recently, their effectiveness in treating COVID-19 was hotly debated by live streamers on overseas social media and we media platforms. These dru...
2021-11-03 22:42
2794
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities inNew Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe GAITHERSBURG, Md., Nov. 3, 20...
2021-11-03 22:14
5240
ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence
PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific leader in medical imaging, the combined company is renamed Clario. Clario is a technology company tha...
2021-11-03 21:33
4265
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...
2021-11-03 15:00
4688
Tabernacle Health Group Launches Revolutionary Immunity Booster!
SINGAPORE, Nov. 3, 2021 /PRNewswire/ -- As a result of the pandemic, boosting one's immune system has never been more crucial. Consisting of numerous chemicals, cells, proteins, and tissues that work together, the immune system is responsible for creating, storing, and distributing white blood ce...
2021-11-03 10:00
3011
Argon Medical Launches Novel Innovations for Portal Vein Access Procedures
FRISCO, Texas, Nov. 2, 2021 /PRNewswire/ -- Argon Medical Devices, Inc., a global manufacturer of specialty devices for Interventional Radiology, Vascular Surgery, and Interventional Cardiology, formally announced the launch of two unique portal vein access sets intended for transjugular liver ac...
2021-11-02 22:53
3514
Phebra Acquires Equity Stake In UK Specialty Hospital Pharma Company Flexipharm Austrading
* Phebra takes part ownership of Flexipharm Austrading through share purchase * Builds on Phebra's Existing UK Distribution Agreement * Strengthens Phebra's Presence in UK and Europe SYDNEY, Nov. 2, 2021 /PRNewswire/ -- Leading Australian pharmaceutical group Phebra Holdings ('Phebra') is pl...
2021-11-02 20:27
2265
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Nautilus
Biotechnology, Inc
2021-11-02 20:16
3802
Diabetes is "a pandemic of unprecedented magnitude" now affecting one in 10 adults worldwide, reveals the International Diabetes Federation
New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes BRUSSELS, Nov. 2, 2021 /PRNewswire/ -- The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living with diabetes...
2021-11-02 16:00
2092
Winner Medical to Showcase Innovations in Wound Care and Infection Prevention at MEDICA 2021
SHENZHEN, China, Nov. 2, 2021 /PRNewswire/ -- Winner Medical (300888.SZ), a leading manufacturer for disposable wound care and surgical products, is set to showcase its full set of advanced solutions for wound care and O.R. infection prevention at MEDICA 2021 which is slated to run fromNovember 1...
2021-11-02 15:18
5786
Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma
SHANGHAI and HONG KONG, Nov. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-11-02 08:30
4653
SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8
New bioinformatic workflow advances analysis capabilities for whole exome assessment and interpretation BOSTON and LAUSANNE, Switzerland, Nov. 1, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven ...
2021-11-01 20:03
3211
MGI Unveils Performance Upgrades for its Sequencing Platforms* and Customized ATOPlex Platform at the 16th International Conference on Genomics
QINGDAO, China, Nov. 1, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a global life science leader and innovator, introduced a series of performance upgrades for its gene sequencing platforms* and a new multiplex PCR platform at the 16th International Conference on Genomics (ICG-16) held inQingd...
2021-11-01 19:52
2574
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
GAITHERSBURG, Md. and PUNE, India, Nov. 1, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine ma...
2021-11-01 18:57
6077
WuXi Biologics Launches a New GMP Commercial Drug Product Facility
* Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production * Increases up to 60 million vials for commercial drug production per year * Consolidates WuXi Biologics' pioneering the application of innovative technologies such as si...
2021-11-01 10:19
7532
Suzhou Ribo Life Science Co. Ltd. Adopts ArisGlobal's LifeSphere® MultiVigilance to Advance Data Management from Clinical Trials
Innovative R&D company selects LifeSphere by ArisGlobal to further develop its safety capabilities MIAMI, Nov. 1, 2021 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform LifeSphe...
2021-11-01 09:00
4290
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma
SHANGHAI and HONG KONG, Nov. 1, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-11-01 08:40
5216
Gannex Announces U.S. IND Approval of ASC43F, a First-in-Class Dual-Target Fixed-Dose Combination for NASH
SHANGHAI, Nov. 1, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), today announces the Investigational New Drug (IND) application approval by U.S. Food and Drug Administration (FDA) and initiation of global development of ASC43F, a first-...
2021-11-01 08:30
3890
Farrer Park Hospital Introduced Actinium-225 PSMA Nuclear Therapy for Advanced Prostate Cancer
Earlier trials using Actinium-225 PSMA showed an improved biochemical response and better cancer-killing effects as Actinium-225 PSMA uses a much more potent radioactive ligand. SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Prostate cancer is the 3rd most common cancer among Singaporean men. Every day...
2021-11-01 08:15
2754
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 310 media titles]
2026-10-27 13:40
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 283 media titles]
2026-10-23 21:52
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00
Most Read
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
42074
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
41688
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
41270
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
33033